Literature DB >> 18197517

Particle characteristics and biodistribution of camptothecin-loaded PLA/(PEG-PPG-PEG) nanoparticles.

Ryotaro Kunii1, Hiraku Onishi, Ken-ichi Ueki, Ken-ichi Koyama, Yoshiharu Machida.   

Abstract

Poly(DL-lactic acid) (PLA)/poly(ethylene glycol)-block-poly (propylene glycol)-block-poly(ethylene glycol) copolymer (PEG-PPG-PEG) nanoparticles loaded with camptothecin (CPT), called CPT-NP, were prepared and examined for particle size change and drug release in phosphate-buffered saline, pH 7.4, (PBS), and drug biodistribution profiles in mice bearing sarcoma 180 solid tumor. CPT-NP kept an almost constant mean size and exhibited an initial rapid release of approximately 20%, following by very slow release. As compared with CPT solution, CPT-NP showed higher tissue accumulation and better tumor localization, which were considered essentially associated with the better efficacy of CPT-NP reported in the previous study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18197517     DOI: 10.1080/10717540701827154

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  3 in total

1.  Preparation, physicochemical characterization and cytotoxicity in vitro of gemcitabine-loaded PEG-PDLLA nanovesicles.

Authors:  Lin Jia; Jian-Jun Zheng; Shu-Man Jiang; Kai-Hong Huang
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

2.  Poly(omega-pentadecalactone-co-butylene-co-succinate) nanoparticles as biodegradable carriers for camptothecin delivery.

Authors:  Jie Liu; Zhaozhong Jiang; Shengmin Zhang; W Mark Saltzman
Journal:  Biomaterials       Date:  2009-07-25       Impact factor: 12.479

3.  Fabrication of anionic dextran-coated micelles for aptamer targeted delivery of camptothecin and survivin-shRNA to colon adenocarcinoma.

Authors:  Setareh Sanati; Sahar Taghavi; Khalil Abnous; Seyed Mohammad Taghdisi; Maryam Babaei; Mohammad Ramezani; Mona Alibolandi
Journal:  Gene Ther       Date:  2021-02-25       Impact factor: 5.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.